Preserve-Transplant Study

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

June 29, 2021

Study Completion Date

July 26, 2021

Conditions
AcidosisRenal InsufficiencyKidney Transplantation
Interventions
DRUG

Nephrotrans

Sodium hydrogen carbonate, ATC-Code: A02AH

OTHER

Placebo

Identical capsules without active substance.

Trial Locations (3)

Unknown

Inselspital Bern, Department of Nephrology and Hypertension, Bern

HUG - Néphrologie, Geneva

University Hospital Zurich, Division of Nephrology, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT03102996 - Preserve-Transplant Study | Biotech Hunter | Biotech Hunter